Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease

Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD)

NCT00365300 ·Status: COMPLETED ·Phase: PHASE3

Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).

NCT00171483 ·Status: COMPLETED ·Phase: PHASE3

Genotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled Asthma

NCT03015610 ·Status: COMPLETED ·Phase: PHASE3

Mechanisms Preventing Pharyngeal Reflux

NCT05696184 ·Status: RECRUITING ·Phase: NA

Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).

NCT00171418 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339)

NCT00163306 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD)

NCT00300755 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole in Pediatric Subjects With Symptomatic Gastroesophageal Reflux Disease

NCT01045096 ·Status: COMPLETED ·Phase: PHASE1

Medical and Surgical Treatment of Esophageal Reflux

NCT00061724 ·Status: COMPLETED

Longitudinal Study of Children With a Chronic Cough and the Impact of Gastroesophageal Reflux

NCT00771706 ·Status: WITHDRAWN ·Phase: PHASE3

An Efficacy and Safety Study of XP19986 in Subjects With Symptomatic GERD

NCT00557401 ·Status: COMPLETED ·Phase: PHASE2

Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343)

NCT00336219 ·Status: COMPLETED ·Phase: PHASE3

Esomeprazole for Treatment of GERD in Pediatric Patients

NCT00228527 ·Status: COMPLETED ·Phase: PHASE4

Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease.

NCT01601379 ·Status: COMPLETED

Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD)

NCT00868296 ·Status: COMPLETED ·Phase: PHASE3

Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study

NCT00235677 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating Pantoprazole in Neonates and Preterm Infants With GERD

NCT00362609 ·Status: COMPLETED ·Phase: PHASE3

What is the Predictive Value of the Reflux Impact Scale

NCT00536328 ·Status: TERMINATED

Which Supraesophageal Reflux Symptoms Reliably Respond to Proton-Pump-Inhibitor (PPI) Therapy

NCT00170001 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate the Effect of Lansoprazole on Infants With Gastroesophageal Reflux Disease.

NCT00220818 ·Status: COMPLETED ·Phase: PHASE1

Management of Esophagitis Following Repair of Esophageal Atresia

NCT03619408 ·Status: UNKNOWN

Gastric Accommodation and Gastroesophageal Reflux

NCT01078064 ·Status: TERMINATED

A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD)

NCT01161602 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease

NCT05890001 ·Status: COMPLETED ·Phase: PHASE3

Acid Reflux and Stromal Fibroblasts in Barrett's Esophagus

NCT00573911 ·Status: COMPLETED ·Phase: PHASE1